These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16864765)

  • 1. The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.
    Cheng HY
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1525. PubMed ID: 16864765
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
    Cowan A; Hylek EM
    J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2.
    Gage BF; Birman-Deych E; Radford MJ; Nilasena DS; Binder EF
    Arch Intern Med; 2006 Jan; 166(2):241-6. PubMed ID: 16432096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 5. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W; Shen DT; Wang YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation.
    Das AK; Willcoxson PD; Corrado OJ; West RM
    Age Ageing; 2007 Jan; 36(1):95-7. PubMed ID: 16799180
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin therapy for elderly persons with atrial fibrillation.
    Ackermann RJ
    Am Fam Physician; 1998 Jul; 58(1):45-6, 48-9. PubMed ID: 9672429
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation in the octogenarian with atrial fibrillation.
    Kapoor M; McNicoll L
    Med Health R I; 2009 Apr; 92(4):152-4. PubMed ID: 19452760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 13. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
    Shroff GR; Solid CA; Herzog CA
    JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
    [No Abstract]   [Full Text] [Related]  

  • 15. Automatic drug use audit in primary care--a pilot evaluation of warfarin use for patients with atrial fibrillation.
    Mortimer CL; Cottrell WN; Comino NJ
    Aust Fam Physician; 2005 Sep; 34(9):798-800. PubMed ID: 16184218
    [No Abstract]   [Full Text] [Related]  

  • 16. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
    Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke prevention versus bleeding risk in atrial fibrillation: a clinical dilemma.
    Hohnloser SH
    J Am Coll Cardiol; 2011 Jan; 57(2):181-3. PubMed ID: 21111556
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.